A clinical trial of Fuzheng Kangai formula combined with PD-1 inhibitors for advanced non-small cell lung cancer based on the interrelation between phlegmdampness syndrome and intestinal flora

Category Primary study
Registry of TrialsInternational Traditional Medicine Clinical Trial Registry
Year 2022
This article has no abstract
Epistemonikos ID: 13dcda537b56ec786e7639bab900956ee7a5d510
First added on: Apr 11, 2025